Professional Bio
Spencer Rosero is an Associate Professor of Medicine and Director of the Hereditary Arrhythmias Clinic.
As a specialist in heart rhythm disorders, Dr. Rosero treats patients using a wide range of therapeutic options including radiofrequency ablation of abnormal rhythms including life threatening rhythms such as ventricular tachycardia, implantation of electronic medical devices such as pacemakers, defibrilllators (ICD's), and cardiac resynchronization therapy devices. He is an experienced clinical investigator and has actively participated in several, large multicenter trials studying the role of medical devices in treating patients with heart failure and life threatening arrhythmias. He joined the University of Rochester faculty in 2000 and received certification from the American Board of Internal Medicine in Internal Medicine, Cardiovascular Disease, and Clinical Cardiac Electrophysiology and Pacing.
His research interests include the design and development of implantable cell based biosensors, clinical evaluation of experimental implantable medical device technologies, and the design and execution of gene-specific pharmacotherapy trials in hereditary arrhythmias such as Long QT syndrome. As the site principal investigator for the early evaluation of a novel implantable left atrial pressure monitoring system at the University of Rochester, Dr. Rosero's team was the first in the nation to implant the St. Jude Heart Pod device.
Dr. Rosero is actively involved in pursuing futuristic medical device technologies that support personalization of medical care. He holds several patents in the field of medical devices.
Patient Care Bio
Spencer Rosero is an Associate Professor of Medicine and Director of the Hereditary Arrhythmias Clinic.
As a specialist in heart rhythm disorders, Dr. Rosero treats patients using a wide range of therapeutic options including radiofrequency ablation of abnormal rhythms including life threatening rhythms such as ventricular tachycardia, implantation of electronic medical devices such as pacemakers, defibrilllators (ICD's), and cardiac resynchronization therapy devices. He is an experienced clinical investigator and has actively participated in several, large multicenter trials studying the role of medical devices in treating patients with heart failure and life threatening arrhythmias. He joined the University of Rochester faculty in 2000 and received certification from the American Board of Internal Medicine in Internal Medicine, Cardiovascular Disease, and Clinical Cardiac Electrophysiology and Pacing.
His research interests include the design and development of implantable cell based biosensors, clinical evaluation of experimental implantable medical device technologies, and the design and execution of gene-specific pharmacotherapy trials in hereditary arrhythmias such as Long QT syndrome. As the site principal investigator for the early evaluation of a novel implantable left atrial pressure monitoring system at the University of Rochester, Dr. Rosero's team was the first in the nation to implant the St. Jude Heart Pod device.
Dr. Rosero is actively involved in pursuing futuristic medical device technologies that support personalization of medical care. He holds several patents in the field of medical devices.
